CURE(IOUS)
LIVE

Serial Number

98032442

Owner

NYSE Group, Inc.

Attorney

Michael A. Geller

Filing Date

Jun 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CURE(IOUS) Trademark

Serial Number: 98032442

CURE(IOUS) is a trademark filed by NYSE Group, Inc. on June 7, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

NYSE Group, Inc.

New York, NY 10005

Entity Type: 03

Trademark Details

Filing Date

June 7, 2023

Registration Date

Not Registered

Published for Opposition

August 26, 2025

Goods & Services

Financial services, namely, providing financial information about health and biotech companies that are listed on a financial exchange for subscribers; financial securities exchange services.

Downloadable interactive computer software and computer hardware for enabling users to view, access, submit, edit and interact with content published from health and biotech companies; downloadable interactive computer software and computer hardware that provides a platform for content from health and biotech companies to publish, display, and share data, information, and videos.

Entertainment services, namely, providing a website featuring photographic, audio, video and prose presentations featuring content from health and biotech companies in the field of health and biotechnology; digital publishing of video, audio, and text of interviews for health and biotech companies.

Providing a website featuring business information from health and biotech companies; publishing of advertising texts for health and biotech companies.

Research and design of interactive computer software and computer hardware for others for providing online services from a global computer network, the Internet, and any other interactive electronic media, namely, software for providing on-line subscription services that enable subscribers to view, access, submit, edit and interact with content published from health and biotech companies via a terminals and mobile communication devices; providing a web site featuring technology that enables users to view, access, submit, edit and interact with content published from companies in the health and biotech industries; providing a web site featuring technology that enables users to access a financial exchange platform for viewing and accessing content from health and biotech companies.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 25, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 24, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 24, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 24, 2026 EEXT
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 23, 2026 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 16, 2025 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 21, 2025 GNS1
SUBSEQUENT FINAL EMAILED
Apr 21, 2025 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Apr 21, 2025 CFRC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 20, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Oct 19, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 18, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 25, 2024 GNFN
FINAL REFUSAL E-MAILED
Jul 25, 2024 GNFR
FINAL REFUSAL WRITTEN
Jul 25, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 23, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 23, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2023 NWOS
NEW APPLICATION ENTERED
Jun 10, 2023 NWAP